The Office of HIV/AIDS Network Coordination (HANC) works with the HIV/AIDS Clinical Trials Networks of the U.S. National Institutes of Health (NIH) with the intent of creating a more integrated, collaborative and flexible research structure. The networks are an affiliated group of national and international medical research institutions and investigators that conduct clinical HIV/AIDS research to develop safe and effective drugs, prevention strategies, and vaccines.
Visit the new AIDS 2022 page on the HANC website to see a summary of all sessions, symposia, and satellites affiliated with the HIV/AIDS Clinical Trials Networks at the International AIDS Conference. This page will continue to be updated as more information becomes available.
Jeffrey Schouten will be retiring from his position as HANC Director on July 1, 2022. There is an ongoing search process for the next HANC Director. In the interim period the Network Leadership Group is pleased to announce that Russell Campbell, HANC Deputy Director, Legacy Project Director, and Community Partners Coordinator, has agreed to serve as the Acting HANC Director until the next HANC Director is hired.
Russell has been with HANC for over fourteen years and HANC Deputy Director for over six years, working closely with Jeff during that time. Jeff has also agreed to serve as a consultant starting August 1, 2022 to assist in the smooth transition during this interim period, and during the onboarding of the next HANC Director.
The Office of HIV/AIDS Network Coordination (HANC) programs are referred to as areas of coordination. Within each area of coordination are numerous work groups that are integral to advancing the research goals and objectives defined by the HIV/AIDS Clinical Trials Networks and the Division of AIDS.
HANC supports a number of trans-institute behavioral science groups composed of experts that are working to advance research and clinical trials through cross-network collaboration.
HANC supports Community Partners, The Legacy Project, and the COVID-19 CAB coalition to achieve representation and build relationships with historically underrepresented communities in clinical research.
HANC supports cross-network working groups for network leadership, communications, data management centers, performance evaluation, and site coordinators to promote greater information sharing, collaboration, and process standardization.
HANC supports several cross-network laboratory working groups and committees with the aim of harmonizing processes and procedures, ensuring standard quality assurance for protocol-specified assays and laboratory preparedness for network clinical trials.
The 2022 IMPAACT Annual Meeting will take place as a hybrid conference to include both virtual and in-person participation from 28 June - 1 July 2022. The in-person component will be hosted at the Washington Hilton Hotel in Washington, D.C., USA.
The hybrid Adherence 2022 conference will take place July 11-13, 2022, at the Mayflower Hotel in Washington, DC, USA, and via an online platform. Sponsored by the International Association of Providers of AIDS Care (IAPAC), this annual series of conferences features the presentation and discussion of HIV treatment and biomedical prevention adherence research, and current behavioral and clinical perspectives in practicum, within the context of optimizing the continuum of HIV care and prevention.
Working together, we can be the generation to end the HIV/AIDS epidemic. Know the facts, spread the word, volunteer for a study, or join a community advisory board.